查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827526

乳房攝影影像市場（按產品、技術、設備類型、類別、影像方式、應用和最終用戶分類）—2025-2032 年全球預測

Breast Imaging Market by Product, Technology, Equipment Type, Category, Imaging Modality, Application, End-User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，乳房攝影影像市場規模將成長至 103.5 億美元，複合年成長率為 8.46%。

主要市場統計數據
基準年2024年 54億美元
預計2025年 58.3億美元
預測年份：2032年 103.5億美元
複合年成長率（%） 8.46%

重新定義乳房攝影採購、部署和護理途徑的臨床要求和技術進步的權威指導

乳房攝影領域正經歷技術快速成熟、臨床重點趨同以及政策審查日益嚴格等諸多變化，這些變化正在重新定義醫療服務提供者、支付方和供應商的檢測和診斷方式。影像硬體和軟體的最新進展，包括多維成像技術的改進以及先進放射學工作流程的整合，正在重塑從篩檢到術前定位的臨床路徑。同時，醫療系統正在平衡資金限制與提高診斷準確性、降低召回率以及擴大醫療服務覆蓋範圍的需求。

相關人員正面臨一系列複雜的選擇：是投資模組化系統以實現模態融合，還是採用行動部署模式來擴大覆蓋範圍，還是優先考慮軟體主導的方法來改善影像判讀和互通性。這些決策受到報銷趨勢、放射科內部員工動態以及人工智慧作為決策支援層加速應用的影響。從類比成像到數位成像的轉變等轉型力量持續影響著採購週期，而監管和資費的發展也為資本規劃增添了許多不確定性。

本介紹為重點執行分析奠定了基礎，該分析綜合了技術趨勢、產品、模式和最終用戶群體細分動態以及區域見解，為戰略規劃提供資訊，目的是讓決策者對重塑乳房攝影的力量有清晰、可行的理解，並使他們能夠優先考慮能夠產生臨床影響和營運彈性的投資。

模式創新、軟體整合和分散式護理模式正在重塑乳房攝影影像的診斷途徑和操作重點

乳房攝影領域正在經歷重大變革，這得益於顯像模式的進步、軟體支援的工作流程以及不斷變化的醫療服務模式，這些模式提高了診斷的準確性和操作的靈活性。3D和高維度顯像模式改善了病變特徵的描述和手術計劃，而造影技術和混合方法則提高了複雜臨床場景中的靈敏度。同時，軟體創新，例如針對斷層合成和MRI最佳化的影像處理軟體以及簡化工作流程和決策支援的放射學軟體，已成為硬體投資的重要補充。

另一個重大變化是向分散式醫療模式的轉變。行動醫療單元和整合系統使篩檢和追蹤服務能夠在傳統醫院環境之外進行，從而擴大了醫療服務的可近性並提高了醫療服務的連續性。隨著系統將影像輸出與電子健康記錄和多學科醫療平台相整合，這種營運模式的轉變與對互通性和資料管治的日益重視不謀而合。同時，人力限制和人工智慧輔助工具的普及迫使醫療系統重新設計放射科工作流程，以提高診療效率並維持品質。

這些轉變凸顯了乳房攝影影像價值的重新定義：成功不再僅僅透過設備效能來衡量，而是透過提供全面的、以患者為中心的診斷途徑的能力來衡量，該途徑結合了多種模式、無縫軟體整合和自適應部署策略，以滿足不斷變化的臨床需求。

不斷變化的關稅政策如何重塑供應鏈、籌資策略和供應商關係，以優先考慮彈性和總擁有成本

美國近期頒布的關稅政策對服務於乳房攝影生態系統的整個供應鏈產生了累積影響，影響了採購時間表、籌資策略和供應商談判。依賴全球化製造佈局的設備製造商已經調整了其供應鏈架構，以緩解不斷上漲的投入成本和關稅，這導致他們重新定位零件採購、重組產品組合，在某些情況下甚至轉移生產地點以保持競爭力。

醫療系統和診斷中心正在重新思考其採購視角，強調整體擁有成本和生命週期支持，而不是僅僅關注領先資本支出。這導致人們對融資模式、延長服務協議和以舊換新計劃的興趣日益濃厚，旨在分散財務影響並保持對先進影像處理功能的使用。此外，供應商擴大在設計產品系列考慮模組化，以實現增量升級，從而降低關稅引發的價格波動的影響。

同時，關稅環境正在加速圍繞近岸外包和供應商多元化的對話，促使相關人員優先考慮擁有韌性本地供應鏈和強大售後服務支援網路的合作夥伴。這種方向的轉變反映出人們越來越認知到，政策主導的成本壓力需要採取靈活的籌資策略，加強臨床團隊與供應鏈領導者之間的合作，並製定積極主動的合約安排，以保障醫療服務的連續性和資本規劃。

綜合細分分析揭示了產品、技術、設備、模式、應用和最終用戶動態如何融合以形成策略機會

市場區隔洞察表明，市場動態是多方面的，反映了產品、技術、設備類型、類別、顯像模式、應用和最終用戶的不同促進因素。系統包括切片檢查引導、乳房核磁共振成像 (MRI)、超音波、乳房 X 光乳房X光攝影和斷層合成設備，而軟體則包括針對特定模式客製化的影像處理平台和放射學解決方案，以提高工作流程效率和診斷一致性。這種交互作用表明，對先進系統的投資通常需要對軟體進行同步投資，以最大限度地提高臨床價值。

技術碎片化凸顯了向多維成像的轉變，3D 和新興的 4D 技術被納入臨床工作流程，以提高病變的可視性和運動特徵。考慮設備類型時，應重點考慮以下選項：專為全面工作流程設計的整合系統、可擴展至區域環境的行動單元，以及以較低的資本投入提供專用功能的獨立設備。類比成像和數位成像之間的差異將繼續影響升級週期和互通性要求。

顯像模式細分涵蓋乳房斷層合成、造影乳房X光攝影、數位乳房X光攝影、核磁共振成像、乳房攝影影像和超音波等多種影像方式。終端使用者細分涵蓋門診手術中心、癌症研究中心、診斷影像中心和醫院，每個中心的營運約束、監管要求和實施路徑各不相同。整合這些細分層級，可以揭示臨床需求與營運可行性之間的契合點，為供應商和服務提供者識別具有高影響力的商機。

美洲、歐洲、中東和非洲以及亞太地區的部署細節將決定採用和規模策略

區域動態正在影響三大宏觀區域（美洲、歐洲、中東和非洲以及亞太地區）的投資重點、技術採用和營運策略。在美洲，投資的促進因素包括：設施整合、對篩檢專案最佳化的關注，以及私人企業的積極進入，這些企業正在加速採用斷層合成技術和先進的軟體平台。同時，監管更新和報銷改革正在推動醫療機構對其影像處理資產進行現代化升級，並採用各種工具來降低召回率並提高診斷信心。

歐洲、中東和非洲的市場格局多元。西歐市場持續優先考慮數位轉型以及顯影劑和磁振造影技術的整合，而中東和非洲市場則往往強調行動篩檢計劃，並透過投資擴充性的診斷影像系統來擴大可及性。這種多元化的市場格局需要製定針對特定區域的市場策略，以應對複雜的監管環境和不同程度的基礎設施成熟度。在亞太地區，快速的都市化和不斷成長的醫療保健投資正在推動對高階醫療設備和便利篩檢解決方案的需求。本地生產和強大的區域供應商生態系統也在影響採購動態，從而能夠提供針對公共和私營部門需求的具有競爭力的產品。

在全部區域，策略重點集中在互通性、勞動力發展和路徑最佳化上，但每個地區都有不同的監管、經濟和基礎設施因素組合，需要採用獨特的部署方法、夥伴關係模式和臨床培訓計畫。

供應商差異化、夥伴關係和卓越服務如何提升競爭優勢並影響不同臨床環境中的採用

乳房攝影影像領域的競爭格局由傳統設備製造商、創新軟體供應商以及專注於特定設備解決方案的新興專家組成。老字型大小企業繼續利用其規模、服務網路以及涵蓋乳房X光攝影X光檢查、超音波、核磁共振成像和斷層合成系統的廣泛產品系列，以保持其在醫院和大型診斷中心的影響力。同時，軟體公司正透過工作流程自動化、人工智慧驅動的檢測和分類功能以及促進遠端讀取和多學科協作的雲端基礎架構來脫穎而出。

新參與企業和細分領域的專家正在透過開發針對行動篩檢最佳化的模組化設備、用於分散式護理的經濟高效的獨立設備以及針對難診人群的顯影劑和分子成像解決方案來填補市場空白。夥伴關係關係和聯盟日益普遍，供應商合作整合影像處理軟體和系統硬體，並共同進行臨床檢驗研究，以證明其在現實世界中的影響。供應商正專注於快速維護回應、培訓計劃和靈活的資金籌措減少停機時間並保障臨床吞吐量。

總的來說，這些企業級動態凸顯了互通性、證據產生和售後參與的重要性，因為在臨床結果和營運連續性驅動購買決策的市場中，它們是差異化因素。

採取切實可行的優先策略行動，協調採購、技術整合和員工準備，以加速臨床影響和營運彈性

尋求抓住市場機會的產業領導者應優先制定一系列切實可行的策略，將技術投資與臨床工作流程和業務目標結合。首先，投資可互通的解決方案，以實現影像處理系統與放射學軟體之間的無縫整合，支援多學科護理路徑，並促進人工智慧的擴展。優先考慮開放標準和可擴展架構，將有助於組織為未來的應用做好準備，並減少升級顯像模式和工作流程工具時的摩擦。

第二，採用靈活的採購和資金籌措結構，平衡資金限制和臨床需求。這包括考慮模組化升級路徑、託管服務協議和資產生命週期夥伴關係，以降低前期成本，同時保持先進影像處理功能的使用。第三，建構具韌性的供應鏈和供應商生態系統，包括實現供應商多元化、優先選擇擁有強大區域支持網路的合作夥伴，並納入應急條款以緩解關稅和貿易中斷的影響。

最後，我們專注於人員和流程，投資於員工發展、臨床培訓和舉措計劃，從而有效率地採用新的醫療模式和軟體。透過實施這些建議，領導者可以釋放更高的診斷價值，改善患者體驗，並在快速發展的環境中獲得永續的競爭優勢。

透明的混合方法研究框架，結合初級臨床醫生研究、監管研究和供應鏈分析，產生可供決策的情報

該分析採用了嚴格的混合方法研究途徑，將定性和定量輸入進行三角測量，以確保為決策提供可靠的見解。主要研究包括結構化訪談和與臨床負責人、放射科主任、採購專家和供應商高管的深入討論，以收集關於採用促進因素、實施挑戰和服務期望的第一手觀點。次要研究則包括全面檢索同儕審查的臨床研究、監管指南和公開的技術規範，以檢驗關鍵顯像模式和軟體功能的效能屬性。

此外，我們還進行了供應鏈和政策分析，以評估關稅變化和貿易動態對營運的影響，重點是製造足跡、組件依賴性和售後支援模式。此外，我們還進行了比較供應商評估，評估了產品系列、整合方法和服務提案，以確定差異化因素和潛在的合作機會。在整個過程中，我們與行業相關人員反覆檢驗研究結果，以確保其準確性、實用性並與不斷變化的臨床和監管趨勢保持一致。

此方法框架確保所提出的見解基於現實世界的實踐，並代表臨床效用、操作可行性和對決策者的策略意義的平衡整合。

關鍵整合強調技術、人才和採購適應性的整合，以確保乳房攝影影像的臨床卓越性和營運彈性。

總而言之，乳房攝影的未來將取決於影像模式創新、軟體主導的工作流程最佳化以及在擴大診療覆蓋範圍的同時保持診斷品質的策略部署模式的相互作用。能夠協調跨系統和影像軟體的投資、採用靈活的採購方式並投資於員工隊伍建立的醫療保健機構，將能夠更好地將技術進步轉化為改善的病患治療效果。包括關稅波動在內的政策變化的累積影響凸顯了供應鏈敏捷性和供應商夥伴關係關係的必要性，這些合作夥伴關係能夠在不影響服務連續性的情況下吸收成本波動。

展望未來，相關人員應關注新興醫療模式的臨床證據，優先考慮互通性以實現可擴展的人工智慧應用，並設計籌資策略以實現漸進式現代化。這將使醫療服務提供者和供應商能夠攜手合作，提高篩檢效率、診斷準確性和以患者為中心的診療路徑。關鍵在於整合技術、人員和流程，以便在快速發展中保持卓越的臨床表現和營運韌性。

目錄

第1章 引言

第2章分析方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 整合人工智慧演算法，實現乳房X光檢查病變的自動檢測與分類
  • 結合 3D 斷層合成和顯影劑增強技術可提高緻密乳房組織中的癌症檢測率
  • 具有靶向放射性示踪劑的分子乳房攝影擴大被用於提高篩檢高風險患者的特異性。
  • 開發可攜式手持超音波設備，用於乳房病變的照護現場評估
  • 擴展融合成像工作流程，整合超音波和 MRI 數據，實現全面的腫瘤表徵
  • 基於深度學習的分割工具的實現，用於自動化乳房組織密度量化和風險分層
  • 低劑量頻譜X光檢查系統的出現，可提供雙能量影像，且不增加輻射曝射量
  • 遠距乳房 X 光攝影平台的興起，使得醫療服務不足和農村地區的醫療保健環境能夠進行遠端讀取和諮詢
  • 加強診斷影像中心與生技公司的合作，開發新的乳癌生物標記

第6章：美國關稅的累積影響（2025年）

第7章：人工智慧（AI）的累積影響（2025年）

第8章乳房攝影診斷市場（按產品）

  • 軟體
    • 診斷影像軟體
    • 放射學軟體
  • 系統
    • 切片檢查引導系統
    • 乳房MRI系統
    • 乳房超音波系統
    • 乳房鉬靶X光攝影系統
    • 斷層合成系統

第9章乳房攝影影像市場（按技術）

  • 2D影像診斷
  • 3D影像診斷
  • 4D影像診斷

第 10 章乳房攝影診斷市場（依設備類型）

  • 整合系統
  • 移動單元
  • 獨立設備

第11章乳房攝影診斷市場分類

  • 類比成像
  • 數位影像

第 12 章乳房攝影影像市場（依影像方式）

  • 乳房斷層攝影
  • 造影X光攝影
  • 數位乳房攝影
  • 磁振造影
  • 分子乳房攝影
  • 超音波影像

第13章乳房攝影診斷市場應用

  • 乳房切片
  • 診斷性乳房X光檢查
  • 術前位置估計
  • 乳房X篩檢

第14章乳房攝影診斷市場（依最終用戶）

  • 門診手術中心
  • 癌症研究中心
  • 診斷影像中心
  • 醫院

第15章乳房攝影診斷市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章乳房攝影診斷市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章乳房攝影診斷市場（按國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Agfa-Gevaert Group
    • Analogic Corporation
    • Aurora Health, Inc.
    • Canon Inc.
    • Carestream Health Inc.
    • CMR Naviscan Corporation
    • Delphinus Medical Technologies, Inc.
    • EIZO Corporation
    • Elekta AB
    • Esaote SpA
    • FUJIFILM Holdings Corporation
    • GE HealthCare
    • Hitachi Ltd.
    • Hologic, Inc.
    • IMS Giotto SpA
    • Konica Minolta, Inc.
    • Koninklijke Philips NV
    • Micrima Limited
    • Mindray Medical International Limited
    • Neusoft Medical Systems Co., Ltd.
    • Planmeca OY
    • Samsung Electronics Co., Ltd.
    • Sectra AB
    • Shanghai United Imaging Healthcare Co., LTD
    • Shimadzu Corporation
    • Siemens Healthineers AG
    • Sonosdetect LLC
    • Trivitron Healthcare Private Limited
Product Code: MRR-43395F955F76

The Breast Imaging Market is projected to grow by USD 10.35 billion at a CAGR of 8.46% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.40 billion
Estimated Year [2025] USD 5.83 billion
Forecast Year [2032] USD 10.35 billion
CAGR (%) 8.46%

An authoritative orientation to clinical imperatives and technological evolution redefining procurement, deployment, and care pathways in breast imaging

The breast imaging landscape is experiencing rapid technological maturation, converging clinical priorities, and heightened policy scrutiny that together redefine how providers, payers, and vendors approach detection and diagnosis. Recent advances in imaging hardware and software, including the refinement of multi-dimensional imaging techniques and the integration of advanced radiology workflows, are reshaping clinical pathways from screening through pre-surgical localization. At the same time, health systems are balancing capital constraints with imperatives to improve diagnostic accuracy, reduce recall rates, and expand access to underserved populations.

In practice, stakeholders are contending with a complex matrix of choices: whether to invest in modular systems that enable modality convergence, adopt mobile deployment models to increase reach, or prioritize software-driven improvements in image interpretation and interoperability. These decisions are influenced by reimbursement trajectories, workforce dynamics within radiology, and the accelerating adoption of artificial intelligence as a decision-support layer. Transitional forces such as migration from analog to digital imaging continue to influence procurement cycles, while regulatory and tariff developments add layers of uncertainty to capital planning.

This introduction sets the stage for a focused executive analysis that synthesizes technology trends, segmentation dynamics across product, modality, and end-user groups, and regional considerations that will inform strategic planning. The goal is to equip decision-makers with a clear, actionable understanding of the forces reshaping breast imaging so they can prioritize investments that deliver clinical impact and operational resilience.

Converging modality innovation, software integration, and distributed care models that are reshaping diagnostic pathways and operational priorities across breast imaging

The landscape of breast imaging is undergoing transformative shifts driven by advances in imaging modalities, software-enabled workflows, and changes in care delivery models that are collectively elevating diagnostic precision and operational flexibility. Three-dimensional and higher-dimensional imaging modalities are improving lesion characterization and surgical planning, while contrast-enhanced techniques and hybrid approaches are enhancing sensitivity in complex clinical scenarios. Concurrently, software innovation-spanning imaging software optimized for tomosynthesis and MRI, alongside radiology software that streamlines workflow and decision support-has become an essential complement to hardware investments.

Another pivotal shift is the movement toward distributed models of care, where mobile units and integrated systems enable screening and follow-up services outside of traditional hospital settings, expanding access and improving continuity of care. This operational transition is matched by a growing emphasis on interoperability and data governance as systems integrate imaging outputs with electronic health records and multidisciplinary care platforms. Meanwhile, workforce constraints and the proliferation of AI-assisted tools are prompting health systems to redesign radiology workflows to maintain quality while increasing throughput.

Together, these shifts underscore a redefinition of value in breast imaging: success is no longer measured solely by equipment capabilities but by the ability to deliver integrated, patient-centered diagnostic pathways that combine modality diversity, seamless software integration, and adaptive deployment strategies to meet evolving clinical needs.

How evolving tariff policies have reshaped supply chains, procurement strategies, and vendor relationships to prioritize resilience and total cost of ownership

Recent tariff policies enacted by the United States have introduced cumulative effects across supply chains that serve the breast imaging ecosystem, influencing procurement timelines, sourcing strategies, and vendor negotiations. Equipment manufacturers that rely on globalized manufacturing footprints have adjusted their supply chain architectures to mitigate increased input costs and customs duties, which has led to a reallocation of component sourcing, reengineering of product configurations, and, in some cases, shifts in production locations to preserve competitiveness.

Health systems and diagnostic centers have responded by re-evaluating procurement horizons, placing greater emphasis on total cost of ownership and lifecycle support rather than upfront capital expenditure alone. As a result, there is heightened interest in financing models, extended service agreements, and trade-in programs that spread financial impact and maintain access to advanced imaging capabilities. Furthermore, vendors are increasingly designing product portfolios with modularity in mind to enable phased upgrades that are less sensitive to tariff-induced price volatility.

In parallel, the tariff environment has accelerated dialogues around nearshoring and supplier diversification, prompting stakeholders to prioritize partners with resilient regional supply chains and robust after-sales support networks. This reorientation reflects a broader recognition that policy-driven cost pressures require adaptive procurement strategies, closer collaboration between clinical teams and supply chain leaders, and proactive contractual arrangements to safeguard continuity of care and capital planning.

Integrated segmentation analysis revealing how product, technology, equipment, modality, application, and end-user dynamics converge to shape strategic opportunities

Segmentation insights reveal that the market's dynamics are multifaceted, reflecting distinct drivers across products, technologies, equipment types, categories, imaging modalities, applications, and end users. From a product perspective, systems and software play complementary roles: systems encompass biopsy guidance, breast MRI, ultrasound, mammography, and tomosynthesis equipment, while software spans imaging platforms tailored to specific modalities and radiology solutions that enhance workflow efficiency and diagnostic consistency. This interplay illustrates how investment in advanced systems often necessitates parallel spending on software to unlock full clinical value.

Technology segmentation underscores a shift toward multidimensional imaging, with 3D and emerging 4D techniques increasingly integrated into clinical workflows to improve lesion conspicuity and motion characterization, while 2D imaging remains a core component of many screening programs. Equipment type considerations highlight choices among integrated systems designed for comprehensive workflows, mobile units that extend reach into community settings, and standalone devices that deliver targeted functionality with lower capital intensity. The category distinction between analog and digital imaging continues to shape upgrade cycles and interoperability requirements, as institutions prioritize digital conversion to enable image sharing and AI applications.

Imaging modality segmentation reveals a broad portfolio across breast tomosynthesis, contrast-enhanced mammography, digital mammography, MRI, molecular breast imaging, and ultrasound, each offering unique clinical advantages that inform application-specific deployment for biopsy, diagnostic mammography, pre-surgical localization, and screening. End-user segmentation spans ambulatory surgical centers, cancer research centers, diagnostic imaging centers, and hospitals, and each setting imposes distinct operational constraints, regulatory obligations, and adoption pathways. Synthesizing these segmentation layers clarifies where clinical demand meets operational feasibility and identifies high-impact opportunities for vendors and providers alike.

Regional deployment nuances across the Americas, Europe, Middle East & Africa, and Asia-Pacific that dictate tailored strategies for adoption and scale

Regional dynamics are influencing investment priorities, technology adoption, and operational strategies across three macro regions: Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, investment is often driven by a combination of institutional consolidation, emphasis on screening program optimization, and active private sector participation that accelerates adoption of tomosynthesis and advanced software platforms. Meanwhile, regulatory updates and reimbursement recalibrations encourage providers to modernize imaging fleets and incorporate tools that reduce recall rates and enhance diagnostic confidence.

In Europe, Middle East & Africa, the environment is diverse: Western European markets continue to prioritize digital transformation and integration of contrast-enhanced and MRI-based techniques, while markets in the Middle East and Africa often focus on expanding access through mobile screening initiatives and investment in scalable imaging systems. This heterogeneous landscape necessitates region-specific go-to-market strategies that account for regulatory complexity and variable infrastructure maturity. In Asia-Pacific, rapid urbanization and expanding healthcare investment are driving demand for both high-end modalities and accessible screening solutions. Local manufacturing and strong regional supplier ecosystems are also influencing procurement dynamics, enabling competitive product offerings that target both public and private sector needs.

Across these regions, strategic priorities converge around interoperability, workforce development, and pathway optimization, yet each region's unique combination of regulatory, economic, and infrastructure factors requires tailored approaches to deployment, partnership models, and clinical training programs.

How vendor differentiation, partnerships, and service excellence are driving competitive advantage and influencing adoption across diverse clinical settings

Competitive dynamics in the breast imaging arena are shaped by a mix of legacy equipment manufacturers, innovative software vendors, and emerging specialists focused on modality-specific solutions. Established players continue to leverage scale, service networks, and broad product portfolios across mammography, ultrasound, MRI, and tomosynthesis systems to maintain footprint in hospitals and large diagnostic centers. At the same time, software companies are differentiating through workflow automation, AI-enabled detection and triage capabilities, and cloud-based architectures that facilitate remote reading and multidisciplinary collaboration.

Newer entrants and niche specialists are targeting gaps in the market by developing modular devices optimized for mobile screening, cost-effective standalone units for decentralized care, and contrast-enhanced or molecular imaging solutions that address challenging diagnostic populations. Partnerships and alliances are increasingly common, with vendors collaborating to integrate imaging software with system hardware and to co-develop clinical validation studies that demonstrate real-world impact. Service and support remain critical competitive levers, as providers place a premium on rapid maintenance response, training programs, and flexible financing that reduce downtime and protect clinical throughput.

Collectively, these company-level dynamics emphasize the importance of interoperability, evidence generation, and post-sale engagement as differentiators in a market where clinical outcomes and operational continuity govern purchasing decisions.

Practical and prioritized strategic actions that align procurement, technology integration, and workforce readiness to accelerate clinical impact and operational resilience

Industry leaders seeking to capitalize on market momentum should prioritize a set of actionable strategies that align technology investments with clinical workflows and business objectives. First, invest in interoperable solutions that enable seamless integration between imaging systems and radiology software to support multidisciplinary care pathways and facilitate AI augmentation. By prioritizing open standards and scalable architectures, organizations can future-proof deployments and reduce friction when upgrading imaging modalities or workflow tools.

Second, adopt flexible procurement and financing structures that balance capital constraints with clinical imperatives. This includes exploring modular upgrade paths, managed service agreements, and asset lifecycle partnerships that reduce upfront burdens while preserving access to advanced imaging capabilities. Third, build resilient supply chain and vendor ecosystems by diversifying suppliers, prioritizing partners with strong regional support networks, and embedding contingency clauses that mitigate tariff and trade disruptions.

Finally, focus on people and process by investing in workforce development, clinical training, and change management initiatives that enable efficient adoption of new modalities and software. Operationalizing these recommendations will help leaders unlock higher diagnostic value, improve patient experience, and achieve sustainable competitive advantage in a rapidly evolving environment.

A transparent mixed-methods research framework combining primary clinician insight, regulatory review, and supply chain analysis to produce decision-ready intelligence

This analysis draws on a rigorous, mixed-methods research approach that triangulates qualitative and quantitative inputs to ensure robust, decision-ready insights. Primary research included structured interviews and in-depth discussions with clinical leaders, radiology directors, procurement specialists, and vendor executives to capture first-hand perspectives on adoption drivers, deployment challenges, and service expectations. Secondary research involved comprehensive review of peer-reviewed clinical studies, regulatory guidance, and publicly available technical specifications to validate performance attributes of key imaging modalities and software capabilities.

Additionally, supply chain and policy analyses were conducted to assess the operational implications of tariff changes and trade dynamics, focusing on manufacturing footprints, component dependencies, and aftermarket support models. Comparative vendor assessments evaluated product portfolios, integration approaches, and service propositions to identify differentiation factors and potential partnership opportunities. Throughout the process, findings were iteratively validated with industry stakeholders to ensure accuracy, practical relevance, and alignment with evolving clinical and regulatory trends.

This methodological framework ensures that the insights presented are grounded in real-world practice and reflect a balanced synthesis of clinical utility, operational feasibility, and strategic implications for decision-makers.

A decisive synthesis emphasizing integration of technology, people, and procurement adaptability to secure clinical excellence and operational resilience in breast imaging

In conclusion, the future of breast imaging will be determined by the interplay between modality innovation, software-driven workflow optimization, and strategic deployment models that extend access while preserving diagnostic quality. Institutions that align investments across systems and imaging software, adopt flexible procurement approaches, and invest in workforce readiness will be better positioned to translate technological advances into improved patient outcomes. The cumulative effects of policy shifts, including tariff dynamics, underscore the need for supply chain agility and vendor partnerships that can absorb cost variability without compromising service continuity.

Looking forward, stakeholders should remain attentive to the clinical evidence base around emerging modalities, prioritize interoperability to enable scalable AI adoption, and design procurement strategies that accommodate phased modernization. By doing so, providers and vendors can collaboratively advance screening efficiency, diagnostic accuracy, and patient-centered care pathways. The imperative is clear: integrate technology, people, and processes in a way that sustains both clinical excellence and operational resilience amidst a period of rapid evolution.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence algorithms for automated lesion detection and classification in mammography
  • 5.2. Adoption of 3D tomosynthesis combined with contrast enhancement for improved cancer detection in dense breast tissue
  • 5.3. Growing use of molecular breast imaging with targeted radiotracers to improve specificity in high-risk patient screening
  • 5.4. Development of portable handheld ultrasound devices with AI guidance for point-of-care breast lesion assessment
  • 5.5. Expansion of fusion imaging workflows integrating ultrasound and MRI data for comprehensive tumor characterization
  • 5.6. Implementation of deep learning-based segmentation tools for automated breast tissue density quantification and risk stratification
  • 5.7. Emergence of low-dose spectral mammography systems offering dual-energy imaging without increasing radiation exposure
  • 5.8. Rise of telemammography platforms enabling remote reading and consultation in underserved or rural healthcare settings
  • 5.9. Introduction of contrast-enhanced mammography protocols to reduce false negatives in early-stage tumor screening
  • 5.10. Increasing collaboration between imaging centers and biotech firms for development of novel breast cancer biomarkers

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Breast Imaging Market, by Product

  • 8.1. Software
    • 8.1.1. Imaging Software
    • 8.1.2. Radiology Software
  • 8.2. Systems
    • 8.2.1. Biopsy Guidance Systems
    • 8.2.2. Breast MRI Systems
    • 8.2.3. Breast Ultrasound Systems
    • 8.2.4. Mammography Systems
    • 8.2.5. Tomosynthesis Systems

9. Breast Imaging Market, by Technology

  • 9.1. 2D Imaging
  • 9.2. 3D Imaging
  • 9.3. 4D Imaging

10. Breast Imaging Market, by Equipment Type

  • 10.1. Integrated Systems
  • 10.2. Mobile Units
  • 10.3. Standalone Devices

11. Breast Imaging Market, by Category

  • 11.1. Analog Imaging
  • 11.2. Digital Imaging

12. Breast Imaging Market, by Imaging Modality

  • 12.1. Breast Tomosynthesis
  • 12.2. Contrast Enhanced Mammography
  • 12.3. Digital Mammography
  • 12.4. Magnetic Resonance Imaging
  • 12.5. Molecular Breast Imaging
  • 12.6. Ultrasound Imaging

13. Breast Imaging Market, by Application

  • 13.1. Breast Biopsy
  • 13.2. Diagnostic Mammography
  • 13.3. Pre-Surgical Localization
  • 13.4. Screening Mammography

14. Breast Imaging Market, by End-User

  • 14.1. Ambulatory Surgical Centers
  • 14.2. Cancer Research Centers
  • 14.3. Diagnostic Imaging Centers
  • 14.4. Hospitals

15. Breast Imaging Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Breast Imaging Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Breast Imaging Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Agfa-Gevaert Group
    • 18.3.2. Analogic Corporation
    • 18.3.3. Aurora Health, Inc.
    • 18.3.4. Canon Inc.
    • 18.3.5. Carestream Health Inc.
    • 18.3.6. CMR Naviscan Corporation
    • 18.3.7. Delphinus Medical Technologies, Inc.
    • 18.3.8. EIZO Corporation
    • 18.3.9. Elekta AB
    • 18.3.10. Esaote S.p.A.
    • 18.3.11. FUJIFILM Holdings Corporation
    • 18.3.12. GE HealthCare
    • 18.3.13. Hitachi Ltd.
    • 18.3.14. Hologic, Inc.
    • 18.3.15. IMS Giotto S.p.A.
    • 18.3.16. Konica Minolta, Inc.
    • 18.3.17. Koninklijke Philips N.V.
    • 18.3.18. Micrima Limited
    • 18.3.19. Mindray Medical International Limited
    • 18.3.20. Neusoft Medical Systems Co., Ltd.
    • 18.3.21. Planmeca OY
    • 18.3.22. Samsung Electronics Co., Ltd.
    • 18.3.23. Sectra AB
    • 18.3.24. Shanghai United Imaging Healthcare Co., LTD
    • 18.3.25. Shimadzu Corporation
    • 18.3.26. Siemens Healthineers AG
    • 18.3.27. Sonosdetect LLC
    • 18.3.28. Trivitron Healthcare Private Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL BREAST IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BREAST IMAGING MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BREAST IMAGING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BREAST IMAGING MARKET SIZE, BY CATEGORY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BREAST IMAGING MARKET SIZE, BY CATEGORY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BREAST IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL BREAST IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BREAST IMAGING MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL BREAST IMAGING MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL BREAST IMAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS BREAST IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL BREAST IMAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. BREAST IMAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. BREAST IMAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BREAST IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BREAST IMAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BREAST IMAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BREAST IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BREAST IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BREAST IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BREAST IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BREAST IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BREAST IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BREAST IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BREAST IMAGING MARKET SIZE, BY RADIOLOGY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BREAST IMAGING MARKET SIZE, BY RADIOLOGY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BREAST IMAGING MARKET SIZE, BY RADIOLOGY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BREAST IMAGING MARKET SIZE, BY RADIOLOGY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BREAST IMAGING MARKET SIZE, BY RADIOLOGY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BREAST IMAGING MARKET SIZE, BY RADIOLOGY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BREAST IMAGING MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BREAST IMAGING MARKET SIZE, BY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BREAST IMAGING MARKET SIZE, BY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BREAST IMAGING MARKET SIZE, BY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BREAST IMAGING MARKET SIZE, BY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BREAST IMAGING MARKET SIZE, BY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BREAST IMAGING MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BREAST IMAGING MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BREAST IMAGING MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BREAST IMAGING MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BREAST IMAGING MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BREAST IMAGING MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST MRI SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST MRI SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST MRI SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST MRI SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST MRI SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST MRI SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST ULTRASOUND SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST ULTRASOUND SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST ULTRASOUND SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST ULTRASOUND SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST ULTRASOUND SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BREAST IMAGING MARKET SIZE, BY MAMMOGRAPHY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BREAST IMAGING MARKET SIZE, BY MAMMOGRAPHY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BREAST IMAGING MARKET SIZE, BY MAMMOGRAPHY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BREAST IMAGING MARKET SIZE, BY MAMMOGRAPHY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BREAST IMAGING MARKET SIZE, BY MAMMOGRAPHY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BREAST IMAGING MARKET SIZE, BY MAMMOGRAPHY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BREAST IMAGING MARKET SIZE, BY TOMOSYNTHESIS SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BREAST IMAGING MARKET SIZE, BY TOMOSYNTHESIS SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BREAST IMAGING MARKET SIZE, BY TOMOSYNTHESIS SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BREAST IMAGING MARKET SIZE, BY TOMOSYNTHESIS SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BREAST IMAGING MARKET SIZE, BY TOMOSYNTHESIS SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BREAST IMAGING MARKET SIZE, BY TOMOSYNTHESIS SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BREAST IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BREAST IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BREAST IMAGING MARKET SIZE, BY 2D IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BREAST IMAGING MARKET SIZE, BY 2D IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BREAST IMAGING MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BREAST IMAGING MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BREAST IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BREAST IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BREAST IMAGING MARKET SIZE, BY 3D IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BREAST IMAGING MARKET SIZE, BY 3D IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BREAST IMAGING MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BREAST IMAGING MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BREAST IMAGING MARKET SIZE, BY 4D IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BREAST IMAGING MARKET SIZE, BY 4D IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BREAST IMAGING MARKET SIZE, BY 4D IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BREAST IMAGING MARKET SIZE, BY 4D IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BREAST IMAGING MARKET SIZE, BY 4D IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BREAST IMAGING MARKET SIZE, BY 4D IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BREAST IMAGING MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BREAST IMAGING MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BREAST IMAGING MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BREAST IMAGING MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BREAST IMAGING MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BREAST IMAGING MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BREAST IMAGING MARKET SIZE, BY MOBILE UNITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BREAST IMAGING MARKET SIZE, BY MOBILE UNITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BREAST IMAGING MARKET SIZE, BY MOBILE UNITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BREAST IMAGING MARKET SIZE, BY MOBILE UNITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BREAST IMAGING MARKET SIZE, BY MOBILE UNITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BREAST IMAGING MARKET SIZE, BY MOBILE UNITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BREAST IMAGING MARKET SIZE, BY STANDALONE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BREAST IMAGING MARKET SIZE, BY STANDALONE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BREAST IMAGING MARKET SIZE, BY STANDALONE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BREAST IMAGING MARKET SIZE, BY STANDALONE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BREAST IMAGING MARKET SIZE, BY STANDALONE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BREAST IMAGING MARKET SIZE, BY STANDALONE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BREAST IMAGING MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BREAST IMAGING MARKET SIZE, BY ANALOG IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BREAST IMAGING MARKET SIZE, BY ANALOG IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BREAST IMAGING MARKET SIZE, BY ANALOG IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BREAST IMAGING MARKET SIZE, BY ANALOG IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BREAST IMAGING MARKET SIZE, BY ANALOG IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BREAST IMAGING MARKET SIZE, BY ANALOG IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST TOMOSYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST TOMOSYNTHESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST TOMOSYNTHESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST TOMOSYNTHESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST TOMOSYNTHESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST TOMOSYNTHESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BREAST IMAGING MARKET SIZE, BY CONTRAST ENHANCED MAMMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BREAST IMAGING MARKET SIZE, BY CONTRAST ENHANCED MAMMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BREAST IMAGING MARKET SIZE, BY CONTRAST ENHANCED MAMMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BREAST IMAGING MARKET SIZE, BY CONTRAST ENHANCED MAMMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BREAST IMAGING MARKET SIZE, BY CONTRAST ENHANCED MAMMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BREAST IMAGING MARKET SIZE, BY CONTRAST ENHANCED MAMMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BREAST IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BREAST IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BREAST IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BREAST IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BREAST IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BREAST IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BREAST IMAGING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BREAST IMAGING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BREAST IMAGING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BREAST IMAGING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BREAST IMAGING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BREAST IMAGING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BREAST IMAGING MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BREAST IMAGING MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BREAST IMAGING MARKET SIZE, BY ULTRASOUND IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BREAST IMAGING MARKET SIZE, BY ULTRASOUND IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BREAST IMAGING MARKET SIZE, BY ULTRASOUND IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BREAST IMAGING MARKET SIZE, BY ULTRASOUND IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BREAST IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC MAMMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC MAMMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC MAMMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC MAMMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC MAMMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC MAMMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BREAST IMAGING MARKET SIZE, BY PRE-SURGICAL LOCALIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BREAST IMAGING MARKET SIZE, BY PRE-SURGICAL LOCALIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BREAST IMAGING MARKET SIZE, BY PRE-SURGICAL LOCALIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BREAST IMAGING MARKET SIZE, BY PRE-SURGICAL LOCALIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BREAST IMAGING MARKET SIZE, BY PRE-SURGICAL LOCALIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BREAST IMAGING MARKET SIZE, BY PRE-SURGICAL LOCALIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BREAST IMAGING MARKET SIZE, BY SCREENING MAMMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BREAST IMAGING MARKET SIZE, BY SCREENING MAMMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BREAST IMAGING MARKET SIZE, BY SCREENING MAMMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BREAST IMAGING MARKET SIZE, BY SCREENING MAMMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BREAST IMAGING MARKET SIZE, BY SCREENING MAMMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BREAST IMAGING MARKET SIZE, BY SCREENING MAMMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BREAST IMAGING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BREAST IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BREAST IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BREAST IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BREAST IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BREAST IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BREAST IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BREAST IMAGING MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BREAST IMAGING MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BREAST IMAGING MARKET SIZE, BY CANCER RESEARCH CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BREAST IMAGING MARKET SIZE, BY CANCER RESEARCH CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BREAST IMAGING MARKET SIZE, BY CANCER RESEARCH CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BREAST IMAGING MARKET SIZE, BY CANCER RESEARCH CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BREAST IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BREAST IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BREAST IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BREAST IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BREAST IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BREAST IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BREAST IMAGING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BREAST IMAGING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS BREAST IMAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS BREAST IMAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS BREAST IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS BREAST IMAGING MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS BREAST IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS BREAST IMAGING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE BREAST IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE BREAST IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE BREAST IMAGING MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE BREAST IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE BREAST IMAGING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 311. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 314. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 315. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 316. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 317. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 318. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 319. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 320. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 321. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 324. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 325. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 326. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 327. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 329. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 330. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 331. AFRICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 332. AFRICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 333. AFRICA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 334. AFRICA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 335. AFRICA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 336. AFRICA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 337. AFRICA BREAST IMAGING MA